Categories: Uncategorized

Alembic Pharmaceuticals gets USFDA final nod for Erlotinib Tablets

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Erlotinib Tablets, 25 mg, 100 mg, and 150 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tarceva Tablets, 25 mg, 100 mg, and 150 mg, of OSI Pharmaceuticals.

Erlotinib Tablets are indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving first-line, maintenance, or second or greater line treatment after progression following at least one prior chemotherapy regimen. Erlotinib Tablet in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Erlotinib Tablets, 25 mg, 100 mg, and 150 mg, have an estimated market size of $37 million for twelve months ending March 2021 according to IQVIA.

Alembic has a cumulative total of 148 ANDA approvals (130 final approvals and 18 tentative approvals) from USFDA.

Medically Speaking Team

Share
Published by
Medically Speaking Team

Recent Posts

“Persistent Headaches: Could They Be a Warning Sign of a Brain Tumor? Insights from Neurologists”

Persistent headaches may be more than just discomfort—they could signal something serious, like a brain…

19 hours ago

HEALTH ALERT: KARNATAKA’S CAKES FOUND CONTAMINATED WITH CANCER-CAUSING ARTIFICIAL COLORS

Recent investigations by Karnataka’s Food Safety and Quality Department have unveiled a troubling situation: a…

19 hours ago

“Empowering Emotional Intelligence: How to Help Your Child Master Emotional Regulation for Lifelong Success”

Discover effective strategies to help your child understand and manage their emotions. Build a strong…

19 hours ago

“Unmasking the Hidden Dangers: How COVID-19 Increases the Risk of Kidney Disease”

Explore the alarming link between COVID-19 and the heightened risk of kidney disease, revealing how…

20 hours ago

“Are Antibiotics Truly Effective? Unveiling the Battle Against Bacterial Infections and Resistance”

Explore the effectiveness of antibiotics in treating bacterial infections while uncovering the pressing issue of…

20 hours ago

GLUCOSE TOLERANCE TEST: IMPORTANT TOOL FOR MANAGING YOUR BLOOD SUGAR AND HEALTH

Glucose plays a crucial role in our body's functioning, serving as the primary energy source…

20 hours ago